Senate Bill Would Force Health Giants to Break Up Doctor, Pharmacy, and Insurance Empires
A senate committee must act next: committee consideration.
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
The FTC and DOJ Antitrust Division are given significant new enforcement responsibilities under this bill, including issuing divestiture guidance within 30 days, reviewing all divestitures, submitting quarterly compliance reports to Congress, and creating a fund for disgorged revenues. This creates a substantial new workload for staff at these agencies, though the bill does not specify additional funding or hiring authority.
Read twice and referred to the Committee on the Judiciary.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
Sens. Elizabeth Warren and Josh Hawley are teaming up to crack down on health care conglomerates that own multiple parts of the industry, including pharmacy benefit managers (PBMs), insurers, and the pharmacies and doctor offices that serve patients.
The measure would force the structural separation of insurers, PBMs, and medical providers. It proposes prohibiting parent companies from owning a medical provider or management services organization and a PBM or insurer simultaneously to address conflicts of interest.
The Break Up Big Medicine Act would prohibit parent companies from simultaneously owning medical providers or management services organizations alongside PBMs or insurers. Violators would face automatic penalties if they fail to comply within 1 year, including profit disgorgement.
No votes or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Break Up Big Medicine Act
Analysis generated by AI. Always verify with official sources.